Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Oxford Instruments plc (OXIG.L)
Abingdon, GB
Established in 1959 and headquartered in Abingdon, UK, Oxford Instruments plc operates as a global technology enterprise dedicated to the innovation, development, manufacturing, rental, sale, and maintenance of sophisticated scientific instruments and systems. Its global footprint extends across the United Kingdom, China, Japan, the United States, Germany, the broader European continent, and the rest of Asia, serving international markets. The company's operations are divided into three core business units: Materials & Characterisation, Research & Discovery, and Service & Healthcare. The extensive product lineup includes advanced atomic force microscopy devices, along with vital tools for research and development that serve a wide array of sectors, including semiconductors, renewable energy, mining, metallurgy, and forensic science. It also supplies specialized etch and deposition processing equipment and solutions critical for applications in power and radio frequency devices, VCSELs/lasers, two-dimensional materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS/sensors, and quantum technologies. Furthermore, Oxford Instruments offers a comprehensive range of low-temperature systems, encompassing wet and magnet systems, advanced instrumentation, and bespoke custom solutions. The company's portfolio also features optical imaging products; Nuclear Magnetic Resonance (NMR) instruments, including spectrometers, quality control/assurance analyzers, and rock core analyzers, which are indispensable across diverse fields such as agriculture, food, automotive, aviation, construction, chemicals, environmental science, illicit drug testing, mining, pharmaceuticals, polymers, rock core analysis, textiles, and educational institutions. The enterprise also provides support products for MRI and CT imaging technologies, alongside scientific cameras, spectroscopy solutions, microscopy systems, and proprietary software. These are integral to applications in astronomy, bio-imaging and life sciences, energy generation and storage, forensics and environmental monitoring, photonics, quantum technology, semiconductors, microelectronics, and data storage. Moreover, Oxford Instruments manufactures X-ray tubes, power supplies, and integrated X-ray sources, catering to the analytical, medical imaging, food quality and packaging inspection, and industrial non-destructive testing (NDT) markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.22% | -10.20% | -2.43% | +12.59% | +41.22% | +40.88% | +52.48% | +5.79% | +36.87% | +322.22% | +623.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 4 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Semiconductors: +12.5%-15.5% Q1'26: -8.8% (vs Q1'24)
-
EPS growth Semiconductors: +22.5%+90.9% ★ Q1'26: +28.6% (vs Q1'24)
-
FCF margin FCF growth · Semiconductors: +38.2%+11.4% ★ Q1'26: +20.7% (vs Q1'24)
-
EBIT margin Semiconductors: +10.7%+15.1% ★ Q1'26: +18.3% (vs Q1'24)
-
ROIC Semiconductors: +6.0%+17.4% ★ Q1'26: +48.2% (vs Q1'24)
-
Share dilution Semiconductors: +0.0%-1.9% ★ Q1'26: -1.8% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Semiconductors: -0.75×0.53× ★ Q1'26: 0.21× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 1996 actual |
Mar 1998 actual |
Mar 1999 actual |
Mar 2000 actual |
Mar 2001 actual |
Mar 2003 actual |
Mar 2006 actual |
Mar 2007 actual |
Mar 2008 actual |
Mar 2009 actual |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 7 Rev. Ana. 5 EPS Ana. |
Mar 2027 7 Rev. Ana. 6 EPS Ana. |
Mar 2028 7 Rev. Ana. 5 EPS Ana. |
Mar 2029 5 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
146.34M
est: 145.65M (+0.5%)
|
172.21M
est: 165.95M (+3.8%)
|
167.81M
est: 175.29M (-4.3%)
|
160.69M
est: 180.33M (-10.9%)
|
185.14M
est: 183.71M (+0.8%)
|
187.26M
est: 188.79M (-0.8%)
|
147.40M
est: 161.38M (-8.7%)
|
161.60M
est: 163.14M (-0.9%)
|
176.50M
est: 180.93M (-2.4%)
|
206.50M
est: 194.04M (+6.4%)
|
211.50M
est: 208.58M (+1.4%)
|
262.30M
est: 251.92M (+4.1%)
|
337.30M
est: 342.94M (-1.6%)
|
350.80M
est: 364.78M (-3.8%)
|
360.10M
est: 360.31M (-0.1%)
|
380.10M
est: 379.46M (+0.2%)
|
319.70M
est: 359.57M (-11.1%)
|
300.20M
est: 360.08M (-16.6%)
|
296.90M
est: 307.01M (-3.3%)
|
314.00M
est: 311.79M (+0.7%)
|
317.40M
est: 337.57M (-6.0%)
|
318.50M
est: 320.47M (-0.6%)
|
367.30M
est: 355.99M (+3.2%)
|
444.70M
est: 447.33M (-0.6%)
|
470.40M
est: 484.72M (-3.0%)
|
500.60M
est: 496.30M (+0.9%)
|
422.66M
418.42M – 427.33M
-14.8% YoY
|
441.33M
433.22M – 460.82M
+4.4% YoY
|
465.46M
464.61M – 466.32M
+5.5% YoY
|
486.80M
477.85M – 508.30M
+4.6% YoY
|
| EBITDA |
25.13M
est: 27.54M (-8.8%)
|
20.58M
est: 37.51M (-45.1%)
|
16.83M
est: 22.89M (-26.5%)
|
4.26M
est: 17.69M (-75.9%)
|
8.93M
est: -12.39M (+172.0%)
|
9.26M
est: 34.99M (-73.5%)
|
5.50M
est: 29.91M (-81.6%)
|
8.30M
est: 7.28M (+14.0%)
|
15.60M
est: 17.52M (-11.0%)
|
3.70M
est: 22.74M (-83.7%)
|
31.30M
est: -7.42M (+522.0%)
|
42.00M
est: 49.16M (-14.6%)
|
58.30M
est: 57.04M (+2.2%)
|
51.60M
est: 62.76M (-17.8%)
|
48.90M
est: 45.44M (+7.6%)
|
24.20M
est: 53.64M (-54.9%)
|
42.60M
est: 11.43M (+272.7%)
|
10.00M
est: 30.36M (-67.1%)
|
48.70M
est: 24.11M (+102.0%)
|
54.30M
est: 97.01M (-44.0%)
|
58.00M
est: 59.20M (-2.0%)
|
71.60M
est: 51.49M (+39.1%)
|
67.40M
est: 54.61M (+23.4%)
|
94.80M
est: 56.29M (+68.4%)
|
93.10M
est: 59.39M (+56.8%)
|
63.10M
est: 93.45M (-32.5%)
|
79.92M
79.12M – 80.80M
-14.5% YoY
|
83.45M
81.92M – 87.14M
+4.4% YoY
|
88.01M
87.85M – 88.18M
+5.5% YoY
|
92.05M
90.36M – 96.11M
+4.6% YoY
|
| EBIT |
21.63M
est: 20.61M (+5.0%)
|
16.01M
est: 15.50M (+3.3%)
|
11.83M
est: 15.42M (-23.3%)
|
-17.72M
est: 11.42M (-255.1%)
|
3.42M
est: -21.29M (+116.0%)
|
3.61M
est: 26.18M (-86.2%)
|
400.0K
est: 22.38M (-98.2%)
|
2.30M
est: -505.4K (+555.1%)
|
6.70M
est: 2.22M (+202.1%)
|
-7.80M
est: 9.01M (-186.6%)
|
20.90M
est: 2.15M (+872.2%)
|
28.60M
est: 12.32M (+132.2%)
|
46.30M
est: 37.44M (+23.7%)
|
30.10M
est: 36.91M (-18.5%)
|
32.20M
est: 32.89M (-2.1%)
|
17.20M
est: 25.65M (-32.9%)
|
21.20M
est: 3.21M (+560.2%)
|
-11.40M
est: 21.12M (-154.0%)
|
33.10M
est: -16.44M (+301.3%)
|
36.80M
est: 38.72M (-5.0%)
|
40.10M
est: 39.14M (+2.4%)
|
54.10M
est: 35.21M (+53.6%)
|
48.80M
est: 37.35M (+30.7%)
|
75.10M
est: 38.49M (+95.1%)
|
73.00M
est: 40.61M (+79.7%)
|
41.20M
est: 69.92M (-41.1%)
|
59.80M
59.19M – 60.46M
-14.5% YoY
|
62.44M
61.29M – 65.19M
+4.4% YoY
|
65.85M
65.73M – 65.97M
+5.5% YoY
|
68.87M
67.60M – 71.91M
+4.6% YoY
|
| Net Income |
13.57M
est: 15.86M (-14.4%)
|
11.04M
est: 15.50M (-28.8%)
|
7.85M
est: 11.62M (-32.4%)
|
-19.47M
est: 8.02M (-342.6%)
|
-64.0K
est: -19.87M (+99.7%)
|
1.24M
est: 3.10M (-60.2%)
|
-3.40M
est: 2.61M (-230.3%)
|
-1.50M
est: -3.44M (+56.4%)
|
2.70M
est: -1.66M (+262.3%)
|
-6.70M
est: 2.90M (-331.4%)
|
13.30M
est: -7.20M (+284.7%)
|
32.20M
est: 16.06M (+100.5%)
|
24.80M
est: 43.83M (-43.4%)
|
22.00M
est: 26.38M (-16.6%)
|
18.20M
est: 21.73M (-16.2%)
|
-6.20M
est: 19.45M (-131.9%)
|
7.00M
est: -5.95M (+217.6%)
|
-25.50M
est: 7.11M (-458.8%)
|
19.60M
est: -17.11M (+214.5%)
|
30.00M
est: 66.05M (-54.6%)
|
33.80M
est: 32.17M (+5.1%)
|
41.80M
est: 29.90M (+39.8%)
|
38.60M
est: 31.72M (+21.7%)
|
58.60M
est: 58.60M (+0.0%)
|
50.70M
est: 50.70M (+0.0%)
|
26.00M
est: 62.88M (-58.7%)
|
56.78M
55.76M – 57.79M
-9.7% YoY
|
64.38M
60.92M – 67.84M
+13.4% YoY
|
74.94M
68.45M – 81.44M
+16.4% YoY
|
77.95M
76.09M – 82.43M
+4.0% YoY
|
| SGA |
—
est: 39.55M (-100.0%)
|
—
est: 38.97M (-100.0%)
|
—
est: 38.98M (-100.0%)
|
—
est: 42.28M (-100.0%)
|
—
est: 42.18M (-100.0%)
|
—
est: 50.25M (-100.0%)
|
18.80M
est: 42.95M (-56.2%)
|
20.30M
est: 32.35M (-37.2%)
|
18.80M
est: 52.13M (-63.9%)
|
19.60M
est: 54.16M (-63.8%)
|
20.00M
est: 60.20M (-66.8%)
|
23.30M
est: 67.76M (-65.6%)
|
32.10M
est: 86.03M (-62.7%)
|
86.00M
est: 85.95M (+0.1%)
|
89.80M
est: 84.95M (+5.7%)
|
99.20M
est: 95.96M (+3.4%)
|
91.20M
est: 93.70M (-2.7%)
|
82.90M
est: 92.60M (-10.5%)
|
94.40M
est: 69.89M (+35.1%)
|
95.20M
est: 83.09M (+14.6%)
|
82.40M
est: 92.02M (-10.5%)
|
79.00M
est: 72.90M (+8.4%)
|
106.30M
est: 77.32M (+37.5%)
|
118.30M
est: 79.69M (+48.4%)
|
133.60M
est: 84.08M (+58.9%)
|
135.20M
est: 110.40M (+22.5%)
|
114.76M
113.60M – 116.02M
+3.9% YoY
|
119.83M
117.62M – 125.12M
+4.4% YoY
|
126.38M
126.15M – 126.61M
+5.5% YoY
|
132.17M
129.74M – 138.01M
+4.6% YoY
|
| EPS |
0.28
est: 0.27 (+3.6%)
|
0.22
est: 0.25 (-11.2%)
|
0.16
est: 0.16 (-0.2%)
|
-0.41
est: 0.17 (-339.9%)
|
0.00
est: 0.04 (-103.5%)
|
0.03
est: 0.05 (-50.6%)
|
-0.07
est: 0.04 (-261.2%)
|
-0.03
est: 0.09 (-133.7%)
|
0.06
est: 0.12 (-51.7%)
|
-0.14
est: 0.14 (-197.4%)
|
0.27
est: 0.16 (+66.7%)
|
0.65
est: 0.41 (+58.1%)
|
0.46
est: 0.59 (-22.4%)
|
0.39
est: 0.69 (-43.2%)
|
0.32
est: 0.65 (-50.7%)
|
-0.11
est: 0.48 (-122.7%)
|
0.12
est: 0.49 (-75.4%)
|
-0.45
est: 0.49 (-192.8%)
|
0.34
est: 0.54 (-37.5%)
|
0.52
est: 0.61 (-15.3%)
|
0.54
est: 0.63 (-14.4%)
|
0.73
est: 0.75 (-2.4%)
|
0.67
est: 0.86 (-22.0%)
|
1.02
est: 1.08 (-5.8%)
|
0.88
est: 1.06 (-16.7%)
|
0.45
est: 1.07 (-58.0%)
|
0.96
0.95 – 0.98
-10.1% YoY
|
1.09
1.04 – 1.16
+13.2% YoY
|
1.24
1.17 – 1.39
+13.3% YoY
|
1.33
1.30 – 1.40
+7.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-06-08 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-06-05 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-06-04 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-06-03 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-06-02 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-06-01 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-29 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 3/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | B- | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree UK Quality Dividend Growth UCITS ETF - GBP UGRW.L | 0.83% | 90.9K | 0.29% |
| 2 | Amundi Prime UK Mid & Small Cap UCITS ETF DR - GBP (D) PRUK.L | 0.83% | 3.53M | 0.05% |
| 3 | Vanguard FTSE 250 UCITS ETF (GBP) Distributing VMID.DE | 0.58% | 15.30M | 0.10% |
| 4 | Vanguard FTSE 250 UCITS ETF VMIG.MI | 0.58% | 15.30M | 0.10% |
| 5 | Xtrackers FTSE 250 UCITS ETF 1D XMCX.L | 0.51% | 197.1K | 0.15% |
| 6 | Invesco FTSE 250 UCITS ETF S250.L | 0.50% | 178.0K | 0.12% |
| 7 | iShares FTSE 250 UCITS ETF MIDD.L | 0.49% | 4.19M | 0.40% |
| 8 | HSBC FTSE 250 UCITS ETF HMCX.L | 0.48% | 326.7K | 0.09% |
| 9 | iShares MSCI UK Small Cap UCITS ETF CUKS.L | 0.44% | 566.5K | 0.58% |
| 10 | iShares MSCI United Kingdom Small-Cap ETF EWUS | 0.44% | 177.8K | 0.59% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard Tyson | Chief Executive Officer & Director | 1M | male |
| Charles John Arthur Holroyd | Group Business Development Director | 132.0K | male |
| Louise Meads | Secretary | — | — |
| Paul Andrew Fry | Chief Financial Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OXIG.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
